Lupin Ltd reported an unanticipated quarterly loss after registering a one-time charge related to litigation over a blood pressure drug. Indian drugmaker created a provision...
Pharmaceutical major Lupin announced that the drug maker had received six observations from USFDA for its Unit 2 plant in Pithampur, Indore on 26 January....